On this page
Read the experiment
The finding and its boundary
The investigators reported attenuation of hippocampal injury and associated behavioral and molecular changes. The study does not establish treatment of stroke or memory loss in patients.
The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats.
- Experiment
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Study system
- Male rats after bilateral common-carotid clamping and reperfusion
- Measured outcome
- Hippocampal injury, behavior and gene expression
- Reported result
- The investigators reported attenuation of hippocampal injury and associated behavioral and molecular changes.
- What this cannot establish
- The study does not establish treatment of stroke or memory loss in patients.
What was actually tested
Male rats after bilateral common-carotid clamping and reperfusion. The investigators measured hippocampal injury, behavior and gene expression. The investigators reported attenuation of hippocampal injury and associated behavioral and molecular changes.
The detail that changes the takeaway
The model's vascular insult and the local application at the operated area are part of the intervention. A consumer memory claim would require a different setting and outcome definition. Gene-expression shifts can help generate hypotheses without demonstrating that cognition is durably improved in people.
How far the result travels
The study does not establish treatment of stroke or memory loss in patients.
Brain injury is not an eye-pressure endpoint
A hippocampal injury model asks about ischemic brain tissue. It does not test everyday memory, cognitive enhancement or recovery in a person after stroke. The essential BPC-157 guide separates this early research from established clinical evidence; the consultation questions address how such a paper changes an actual treatment decision.
References & product documents
The evidence and service information used here.